13F
← All fund report cards

AMERICAN CENTURY COMPANIES INC

13F equity value
$194.3B
Positions
2,830
Top 10 concentration
24.1%
Quarters / total new picks
32 / 3,186
13F equity value over time
$0M$99B$199B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.6% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 50.0% of quarters (excess t = 1.39, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.1%
t-stat
1.39
Quarterly win rate
50%
Annualized excess
-1.5%
$1 → follow vs universe
$1.87 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.05720180630: follow 0.96720180930: follow 1.00320181231: follow 0.99920190331: follow 1.01120190630: follow 1.07420190930: follow 1.13320191231: follow 0.87520200331: follow 1.06520200630: follow 1.18020200930: follow 1.55720201231: follow 1.65920210331: follow 1.69320210630: follow 1.80120210930: follow 1.54820211231: follow 1.34320220331: follow 1.40720220630: follow 1.26320220930: follow 1.34220221231: follow 1.27320230331: follow 1.36820230630: follow 1.27520230930: follow 1.49320231231: follow 1.54920240331: follow 1.50120240630: follow 1.71420240930: follow 1.78520241231: follow 1.54220250331: follow 1.75520250630: follow 1.77320250930: follow 2.00820251231: follow 1.870 0.81 1.53 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 2830 · 2026 Q1

Ticker Value Weight QoQ
NVDA $10.6B
5.5%
TRIM
AAPL $6.4B
3.3%
TRIM
MSFT $6.0B
3.1%
ADD
AMZN $5.1B
2.6%
TRIM
GOOGL $5.0B
2.6%
TRIM
AVGO $3.0B
1.5%
ADD
META $2.9B
1.5%
HOLD
GOOG $2.7B
1.4%
TRIM
MA $2.7B
1.4%
TRIM
TSLA $2.5B
1.3%
HOLD
TSM $2.1B
1.1%
TRIM
NFLX $1.9B
1.0%
ADD
COST $1.8B
0.9%
ADD
LLY $1.7B
0.9%
HOLD
AMAT $1.2B
0.6%
TRIM
JPM $1.1B
0.6%
HOLD
ADI $1.0B
0.5%
TRIM
ISRG $972M
0.5%
HOLD
XOM $892M
0.5%
HOLD
VRT $834M
0.4%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.